John X. He

555 total citations
17 papers, 455 citations indexed

About

John X. He is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, John X. He has authored 17 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Oncology. Recurrent topics in John X. He's work include Chemical Synthesis and Analysis (9 papers), Nitric Oxide and Endothelin Effects (6 papers) and Receptor Mechanisms and Signaling (5 papers). John X. He is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Nitric Oxide and Endothelin Effects (6 papers) and Receptor Mechanisms and Signaling (5 papers). John X. He collaborates with scholars based in United States. John X. He's co-authors include Wayne L. Cody, Annette M. Doherty, Joseph A. Loo, Michael D. Reily, Yuan Tu, Vincent P. Rocco, David B. Wainscott, David L. Nelson, Sheila P. Little and Tinggui Yin and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

John X. He

17 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John X. He United States	11	323	147	107	70	67	17	455
James J. Knittel United States	14	414 1.3×	99 0.7×	47 0.4×	68 1.0×	54 0.8×	31	840
M M King United States	14	647 2.0×	163 1.1×	71 0.7×	34 0.5×	27 0.4×	17	786
Masataka Suzuki Japan	17	388 1.2×	119 0.8×	82 0.8×	88 1.3×	74 1.1×	41	919
Alain Boudon France	8	524 1.6×	455 3.1×	140 1.3×	126 1.8×	59 0.9×	10	859
Chidochangu P. Mpamhanga United Kingdom	8	438 1.4×	113 0.8×	53 0.5×	66 0.9×	22 0.3×	10	635
S. Skerratt United Kingdom	13	316 1.0×	103 0.7×	66 0.6×	113 1.6×	20 0.3×	19	561
Mark W. Trumbore United States	13	282 0.9×	54 0.4×	74 0.7×	74 1.1×	25 0.4×	19	542
Kosterin Sa Ukraine	10	235 0.7×	74 0.5×	83 0.8×	103 1.5×	77 1.1×	136	481
Thomas M. Argentieri United States	15	422 1.3×	139 0.9×	52 0.5×	154 2.2×	28 0.4×	34	800
Stephen C. McKeown United Kingdom	11	418 1.3×	105 0.7×	50 0.5×	114 1.6×	108 1.6×	21	665

Countries citing papers authored by John X. He

Since Specialization

Citations

This map shows the geographic impact of John X. He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John X. He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John X. He more than expected).

Fields of papers citing papers by John X. He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John X. He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John X. He. The network helps show where John X. He may publish in the future.

Co-authorship network of co-authors of John X. He

This figure shows the co-authorship network connecting the top 25 collaborators of John X. He. A scholar is included among the top collaborators of John X. He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John X. He. John X. He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wainscott, David B., Sheila P. Little, Tinggui Yin, et al.. (2006). Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1. Journal of Pharmacology and Experimental Therapeutics. 320(1). 475–485. 88 indexed citations

Cody, Wayne L., Annette M. Doherty, Jeremy J. Edmunds, et al.. (1999). The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1. Bioorganic & Medicinal Chemistry Letters. 9(17). 2497–2502. 10 indexed citations

Cody, Wayne L., Corinne E. Augelli‐Szafran, Annette M. Doherty, et al.. (1999). The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2. Bioorganic & Medicinal Chemistry Letters. 9(17). 2503–2508. 3 indexed citations

Cody, Wayne L., John DiMaio, Annette M. Doherty, et al.. (1998). Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 Modifications. Bioorganic & Medicinal Chemistry Letters. 8(23). 3409–3414. 18 indexed citations

Loo, Joseph A., John X. He, & Wayne L. Cody. (1998). Higher Order Structure in the Gas Phase Reflects Solution Structure. Journal of the American Chemical Society. 120(18). 4542–4543. 48 indexed citations

Cody, Wayne L., John X. He, Michael D. Reily, et al.. (1997). Design of a Potent Combined Pseudopeptide Endothelin-A/Endothelin-B Receptor Antagonist, Ac-dBhg¹⁶-Leu-Asp-Ile-[NMe]Ile-Trp²¹(PD 156252): Examination of Its Pharmacokinetic and Spectral Properties. Journal of Medicinal Chemistry. 40(14). 2228–2240. 81 indexed citations

He, John X., et al.. (1997). An efficient preparation of the potent and selective pseudopeptide thrombin inhibitor, inogatran. Bioorganic & Medicinal Chemistry Letters. 7(12). 1563–1566. 11 indexed citations

Stewart, Barbra H., Eric L. Reyner, Roger N. Hayes, et al.. (1996). In vitro assessment of oral delivery for hexapeptide endothelin antagonists. Life Sciences. 58(12). 971–982. 9 indexed citations

Cody, Wayne L., John X. He, Elizabeth A. Lunney, et al.. (1996). Modifications of the C-Terminal Dipeptide of Angiotensin II Yielded a Novel Series of Analogues with Type II (AT2)Receptor Selectivity. Protein and Peptide Letters. 3(2). 107–112. 2 indexed citations

10.

Cody, Wayne L., John X. He, Daniele M. Leonard, et al.. (1995). Structure-activity relationships of the potent combined endothelinA/endothelinB receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21 (PD 142893): development of endothelinB receptor selective antagonists. Journal of Medicinal Chemistry. 38(15). 2809–2819. 21 indexed citations

11.

Sefler, Andrea M., John X. He, Tomi K. Sawyer, et al.. (1995). Design and Structure-Activity Relationships of C-Terminal Cyclic Neurotensin Fragment Analogs. Journal of Medicinal Chemistry. 38(2). 249–257. 36 indexed citations

12.

He, John X., Wayne L. Cody, Michael A. Flynn, et al.. (1995). Res-701-1, synthesis and a reevaluation of its effects on the endothelin receptors. Bioorganic & Medicinal Chemistry Letters. 5(6). 621–626. 13 indexed citations

13.

He, John X., Wayne L. Cody, & Annette M. Doherty. (1995). An Efficient Preparation of the Pseudopeptide Endothelin-B Receptor Selective Antagonist BQ-788. The Journal of Organic Chemistry. 60(25). 8262–8266. 8 indexed citations

14.

Heyl, Deborah, John X. He, Tomi K. Sawyer, et al.. (1994). Structure‐activity and conformational studies of a series of modifiedC‐terminal hexapeptide neurotensin analogues. International journal of peptide & protein research. 44(3). 233–238. 33 indexed citations

15.

He, John X., Wayne L. Cody, & Annette M. Doherty. (1994). An efficient strategy for the large-scale synthesis of head-to-tail cyclic peptides. Letters in Peptide Science. 1(1). 25–30. 5 indexed citations

16.

Cody, Wayne L., John X. He, Stephen T. Rapundalo, et al.. (1994). Structure-activity relationships in a series of monocyclic endothelin analogues. Bioorganic & Medicinal Chemistry Letters. 4(4). 567–572. 3 indexed citations

17.

Cody, Wayne L., Annette M. Doherty, John X. He, et al.. (1992). Design of a functional hexapeptide antagonist of endothelin. Journal of Medicinal Chemistry. 35(17). 3301–3303. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact